Post placeholder image
August 29, 2022 in Kineta Press Release

Kineta Announces the Filing of a Registration Statement on Form S-4 with the U.S. SEC Related to the Reverse Merger with Yumanity Therapeutics (YMTX)

BOSTON, Aug. 29, 2022 -- Yumanity Therapeutics, Inc. ("Yumanity") (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying t ...

Read More